Adamas Pharmaceuticals

-$0.10 (-2.05%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADMS and other ETFs, options, and stocks.

About ADMS

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric.

CEO
Neil F. McFarlane
Employees
138
Headquarters
Emeryville, California
Founded
2000

ADMS Key Statistics

Market Cap
217.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
179.61K
High Today
$4.90
Low Today
$4.76
Open Price
$4.90
Volume
106.67K
52 Week High
$9.15
52 Week Low
$2.96

ADMS News

Simply Wall StSep 18

What Kind Of Investors Own Most Of Adamas Pharmaceuticals, Inc.?

If you want to know who really controls Adamas Pharmaceuticals, Inc. ( ), then you'll have to look at the makeup of its share registry. Institutions will often

ADMS Earnings

-$0.85
-$0.57
-$0.28
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure